25
Views
3
CrossRef citations to date
0
Altmetric
Drug Evaluation

Pharmacoeconomic aspects of memantine (Ebixa®) in the treatment of Alzheimer’s disease

Pages 675-680 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Youyu Wang, Bo Jiang & Wang Luo. (2022) Memantine ameliorates oxaliplatin-induced neurotoxicity via mitochondrial protection. Bioengineered 13:3, pages 6688-6697.
Read now
Anees Shajhan Ebrahem & Mark Oremus. (2018) A pharmacoeconomic evaluation of cholinesterase inhibitors and memantine for the treatment of Alzheimer’s disease. Expert Opinion on Pharmacotherapy 19:11, pages 1245-1259.
Read now

Articles from other publishers (1)

O. S. Egorov, N. Yu. Borisova, E. Ya. Borisova, M. L. Rezhabbaev, E. Yu. Afanas’eva & E. V. Arzamastsev. (2021) Structure and biological action of analogs and derivatives of biogenic polyamines. Fine Chemical Technologies 16:4, pages 287-306.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.